We're building a better ClinicalTrials.gov. Check it out and tell us what you think!

Key Record Dates

ClinicalTrials.gov Identifier: NCT05408312
Brief Title: Phase I Clinical Trial of GEN2-Recombinant COVID-19 Vaccine (CHO Cells) in Healthy People Aged 18 and Above

First Submitted : June 5, 2022
First Submitted that Met QC Criteria : June 5, 2022
First Posted : June 7, 2022

Last Update Submitted that Met QC Criteria : July 20, 2022
Last Update Posted : July 22, 2022